1. Mutant Gene Identified That Causes Abnormal Chromosome Count, Leading to Cancer   Inexpensive Method Detects ALK Rearrangement in Lung Cancer Patients   DANIEL ALEJANDRO…

Slide 1Personalised Cancer Medicine in Phase 1 Cancer Research at Rigshospitalet Ulrik Lassen MD, PH.D Phase 1 Unit Slide 2 Background New targeted therapy is selected according…

Slide 1 UNIVERSITY OF TORINO – DEPARTMENT OF ONCOLOGY Treatment of ALK- and ROS-1 translocated NSCLC Massimo Di Maio, MD Department of Oncology, University of Torino [email protected]…

Stem Cells In Clinical Practice: STELLA Experience Manolo DâArcangelo Department of Oncology Ospedale Civile di Livorno Stem cells in clinical practice: from bench to bedside…

EML4-ALK: Oncogene Addiction Meets Personalized Medicine Thomas J Lynch, MD Jonathan and Richard Sackler Professor of Internal Medicine Director, Yale Cancer Center Physician-in-Chief,…

Personalised Cancer Medicine in Phase 1 Cancer Research at Rigshospitalet Ulrik Lassen MD, PH.D Phase 1 Unit Personalised Medicine - Phase 1Titel/beskrivelse (Sidehoved/fod)…